OTC: SNYNF
Market closed
--Quotes are delayed by 20 min
Nov 30, 2023, 9:43 a.m.
$
92.76
Change
-0.32 -0.35%
Volume
Volume 493
Quotes are delayed by 20 min
Previous close
$ 93.08
$ 92.76
Change
-0.32 -0.35%
Day low
Day high
$92.76
$92.76
52 week low
52 week high
$86.12
$114.90
Mr. Paul Hudson Chief Executive Officer & Director |
Ms. Madeleine Roach Head-Business Operations & Executive VP |
Mr. Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President |
Dr. Dietmar P. Berger Chief Medical Officer & Global Head-Development |
Mr. Emmanuel Frenehard Chief Digital Officer |
Dr. Houman Ashrafian Head-Research & Development |
Dr. Nestle Frank Global Head-Immunology Therapeutic Research Area |
Ms. Julie van Ongevalle Executive VP & Head-Consumer Healthcare |
Ms. Alexandra Roger Head-Securities Law & Capital Markets |
Mr. Brendan OCallaghan Executive Vice President & Head-Industrial Affairs |
Mr. Josep Catlla Head-Communication |
Mr. Raj Verma Chief Diversity, Culture & Experience Officer |
Mr. Olivier Antoine M. Charmeil Executive Vice President-General Medicines |
Mr. Yann Tran Director |
Dr. Wolfgang Laux Director |
Mr. Dave Stevenson Director |
Mr. Serge Weinberg Honorary Chairman |
Mr. Christophe Babule Director |
Ms. Eva Sch?fer-Jansen Head-Investor Relations |
Ms. Natalie Bickford Chief People Officer & Executive Vice President |
Ms. Claire Terrazas Vice President-Corporate Legal Affairs |
Mr. Roy Papatheodorou EVP, General Counsel & Head-Legal |
Mr. Arnaud Del?pine Investor Relations Contact |
Mr. Fr?d?ric Oud?a Chairman |
Ms. Rachel Duan Independent Non-Executive Director |
Ms. Lise Kingo Independent Director |
Mr. Gilles Schnepp Independent Director |
Ms. Barbara Lavernos Independent Director |
Ms. Carole Gabriella Ferrand Independent Director |
Dr. Emile Voest Independent Director |
Dr. Antoine Yver Independent Director |
Ms. Fabienne Lecorvaisier Independent Director |
Mr. Patrick Kron Independent Director |
Ms. Diane D. Souza Independent Director |
Dr. Thomas C. S?dhof Independent Director |
Tesla, Dell, Marvell, Ulta, Samsara, UiPath, Elastic, and More Stock Market Movers
Endless Shrimp deal meant endless pain for Red Lobster’s owner
Bond yields continue to ease after biggest monthly drop in four years
Marvell Stock Drops After Earnings. Analysts Say Be Patient on the AI Story.
Daily Mail owner DMGT teams up with Moore Capital to invest in energy transition ventures
S&P 500 futures steady after 520-point Dow surge, as Powell comments awaited
It’s a brave new workplace: How to close the generation gap among workers
Review: The Ford Bronco Sport gets updates for 2024 and a new retro trim—you’ll dig it
Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives.
Buy This Stock. It Has 50 Years of Dividend Growth—and There's More to Come.
Bristol Myers Stock Is Slumping. One Director Bought Up Shares.
Don't Mind the Geopolitics. The Case for International Investing Is Strong.
Virtual Stock Exchange